Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shell
SHEL
|
+$972M |
| 2 |
Meta Platforms (Facebook)
META
|
+$324M |
| 3 |
Webster Financial
WBS
|
+$279M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Advanced Micro Devices
AMD
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$780M |
| 2 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$335M |
| 3 |
STL
Sterling Bancorp
STL
|
+$283M |
| 4 |
SC
SANTANDER CONSUMER USA HOLDINGS INC
SC
|
+$252M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$241M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.89% |
| 2 | Technology | 16.14% |
| 3 | Industrials | 12.35% |
| 4 | Healthcare | 10.84% |
| 5 | Consumer Discretionary | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Vista Energy
VIST
$7.73B
| $502K | ﹤0.01% |
55,186
+34,425
| +166% | +$248K |
|
|
AENZ
3152
DELISTED
Aenza S.A.A.
AENZ
| $501K | ﹤0.01% |
101,668
| – | – |
|
3153
Dianthus Therapeutics
DNTH
$5.83B
| $500K | ﹤0.01% |
10,758
-480
| -4% | -$26.2K |
|
3154
Usio Inc
USIO
$58.5M
| $500K | ﹤0.01% |
139,784
+3,525
| +3% | +$12.3K |
|
3155
Futu Holdings
FUTU
$14.7B
| $494K | ﹤0.01% |
14,369
| – | – |
|
3156
United Bancorp
UBCP
$89.8M
| $490K | ﹤0.01% |
27,168
+617
| +2% | +$10.6K |
|
|
SFBC
3157
Sound Financial Bancorp
SFBC
$110M
| $486K | ﹤0.01% |
12,750
| – | – |
|
3158
Tarsus Pharmaceuticals
TARS
$2.53B
| $485K | ﹤0.01% |
28,855
+19,865
| +221% | +$369K |
|
3159
Dyne Therapeutics
DYN
$4.61B
| $484K | ﹤0.01% |
50,278
+14,266
| +40% | +$121K |
|
3160
PagSeguro Digital
PAGS
$2.68B
| $478K | ﹤0.01% |
23,839
+3,695
| +18% | +$68.8K |
|
|
KLRS
3161
Kalaris Therapeutics
KLRS
$82.1M
| $476K | ﹤0.01% |
3,060
+927
| +43% | +$185K |
|
|
ALPN
3162
DELISTED
Alpine Immune Sciences Inc
ALPN
| $476K | ﹤0.01% |
53,064
| – | – |
|
3163
Affirm
AFRM
$23.9B
| $475K | ﹤0.01% |
10,266
+1,010
| +11% | +$52.9K |
|
|
EDR
3164
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $475K | ﹤0.01% |
+16,082
| New | +$489K |
|
|
ICD
3165
DELISTED
Independence Contract Drilling, Inc.
ICD
| $475K | ﹤0.01% |
114,996
+64,156
| +126% | +$252K |
|
3166
CPI Aerostructures
CVU
$64.1M
| $472K | ﹤0.01% |
159,963
-81,059
| -34% | -$212K |
|
3167
Fidelity D&D Bancorp
FDBC
$306M
| $471K | ﹤0.01% |
10,145
| – | – |
|
|
FNHC
3168
DELISTED
FedNat Holding Company Common Stock
FNHC
| $471K | ﹤0.01% |
349,091
-158,270
| -31% | -$212K |
|
|
NOTV
3169
DELISTED
Inotiv
NOTV
| $469K | ﹤0.01% |
17,909
-78,294
| -81% | -$2.2M |
|
3170
Paysafe
PSFE
$418M
| $469K | ﹤0.01% |
+11,507
| New | +$475K |
|
3171
SelectQuote
SLQT
$131M
| $461K | ﹤0.01% |
165,128
+17,709
| +12% | +$85.3K |
|
3172
Riley Exploration Permian
REPX
$733M
| $458K | ﹤0.01% |
+18,098
| New | +$486K |
|
3173
Marchex
MCHX
$77.1M
| $450K | ﹤0.01% |
196,700
-4,169
| -2% | -$9.38K |
|
|
OCDX
3174
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $444K | ﹤0.01% |
23,782
+12,051
| +103% | +$217K |
|
3175
Altimmune
ALT
$546M
| $443K | ﹤0.01% |
72,702
-5,768
| -7% | -$42.5K |
|
Similar funds
Dimensional Fund Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Dimensional Fund Advisors held 3,635 positions worth $325B, down 1.9% from $331B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dimensional Fund Advisors's Q1 2022 filing shows 98 new, 2,062 increased, 1,167 reduced and 121 closed positions. Its largest new stake was Shell: 18,315,111 shares worth $1.01B. The largest sale was Royal Dutch Shell PLC ADS Class B, an estimated $780M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.
- Dimensional Fund Advisors's largest Q1 2022 buy was Shell: 18,315,111 shares worth $1.01B.
- Dimensional Fund Advisors added most to Meta Platforms (Facebook) in Q1 2022, an estimated $324M increase.
- Dimensional Fund Advisors's biggest Q1 2022 reduction was Canadian Pacific Kansas City, cutting an estimated $241M.
- Dimensional Fund Advisors fully exited Royal Dutch Shell PLC ADS Class B in Q1 2022, selling an estimated $780M.
- Dimensional Fund Advisors's ten largest holdings make up 11% of its $325B portfolio in Q1 2022.
- Dimensional Fund Advisors opened 98 new positions and closed 121 in Q1 2022.
- Dimensional Fund Advisors's portfolio value fell 1.9% quarter-over-quarter to $325B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2022, filed 13 May 2022.